SCHEMBL8237113

SCHEMBL8237113

CCc1ccc(OC)cc1CC(=O)N(C)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 1/20 0.45
CLK1 P49759 1/20 0.43
DYRK1A Q13627 1/20 0.43
DYRK1B Q9Y463 1/20 0.43
PTGS1 P23219 1/20 0.42
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
POLB P06746 1/20 0.40
ALOX5 P09917 1/20 0.40
HSP90AA1 P07900 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14364305 0.85 HSD17B10 (0.65) ALDH1A1HSD17B10MTNR1AMTNR1B
SCHEMBL19143523 0.81 CLK1 (0.40) ALDH1A1HSD17B10CLK1DYRK1ADYRK1B
SCHEMBL8237110 0.78 HSD17B10 (0.50) ALDH1A1HSD17B10PTGS1AKR1C3AKR1C2
SCHEMBL12431134 0.76 HSD17B10 (0.48) HSD17B10POLB
SCHEMBL1708481 0.76 HTT (0.56) ALDH1A1POLBALOX5KDM4EHTT
SCHEMBL16929973 0.75 KDM4E (0.41) ALDH1A1AKR1C3AKR1C2KDM4ENPC1
SCHEMBL11948699 0.75 MAPT (0.58) ALDH1A1POLBKDM4ELMNAHPGD
SCHEMBL13980506 0.75 NPC1 (0.54) HSD17B10HSP90AA1NPC1LMNAHTT
SCHEMBL904249 0.74 SIGMAR1 (0.57) ALDH1A1POLBHTTMTNR1AMTNR1B
SCHEMBL9112759 0.73 MAPT (0.38) ALDH1A1CLK1DYRK1ADYRK1BALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007087427-A2 THIAZOLE AND THIADIAZOLE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed